BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Growth was broad-based across segments
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Subscribe To Our Newsletter & Stay Updated